ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

(R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability

Cite this: J. Med. Chem. 1994, 37, 12, 1889–1893
Publication Date (Print):June 1, 1994
    ACS Legacy Archive

    Article Views





    Other access options

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 268 publications.

    1. Shannon N. Mostyn, Tristan Rawling, Sarasa Mohammadi, Susan Shimmon, Zachary J. Frangos, Subhodeep Sarker, Arsalan Yousuf, Irina Vetter, Renae M. Ryan, Macdonald J. Christie, Robert J. Vandenberg. Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain. Journal of Medicinal Chemistry 2019, 62 (5) , 2466-2484.
    2. Yingpeng Liu, Lipin Ji, Marsha Eno, Shalley Kudalkar, Ai-Ling Li, Marion Schimpgen, Othman Benchama, Paula Morales, Shu Xu, Dow Hurst, Simiao Wu, Khadijah A. Mohammad, JodiAnne T. Wood, Nikolai Zvonok, Demetris P. Papahatjis, Han Zhou, Chandrashekhar Honrao, Ken Mackie, Patricia Reggio, Andrea G. Hohmann, Lawrence J. Marnett, Alexandros Makriyannis, Spyros P. Nikas. (R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes. Journal of Medicinal Chemistry 2018, 61 (19) , 8639-8657.
    3. Jahnabi Roy, Josephine E. Watson, In Sup Hong, Timothy M. Fan, Aditi Das. Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides. Journal of Medicinal Chemistry 2018, 61 (13) , 5569-5579.
    4. David R. Janero and Alexandros Makriyannis . Terpenes and Lipids of the Endocannabinoid and Transient-Receptor-Potential-Channel Biosignaling Systems. ACS Chemical Neuroscience 2014, 5 (11) , 1097-1106.
    5. Alexandros Makriyannis . 2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective. Journal of Medicinal Chemistry 2014, 57 (10) , 3891-3911.
    6. Sangdon Han, Jayant Thatte, Daniel J. Buzard, and Robert M. Jones . Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists. Journal of Medicinal Chemistry 2013, 56 (21) , 8224-8256.
    7. Lidia Martín-Couce, Mar Martín-Fontecha, Samanta Capolicchio, María L. López-Rodríguez, and Silvia Ortega-Gutiérrez . Development of Endocannabinoid-Based Chemical Probes for the Study of Cannabinoid Receptors. Journal of Medicinal Chemistry 2011, 54 (14) , 5265-5269.
    8. Laurence Balas, Thierry Durand, Sattyabrata Saha, Inneke Johnson and Somnath Mukhopadhyay. Total Synthesis of Photoactivatable or Fluorescent Anandamide Probes: Novel Bioactive Compounds with Angiogenic Activity. Journal of Medicinal Chemistry 2009, 52 (4) , 1005-1017.
    9. Chen Li,, Wei Xu,, Subramanian K. Vadivel,, Pusheng Fan, and, Alexandros Makriyannis. High Affinity Electrophilic and Photoactivatable Covalent Endocannabinoid Probes for the CB1 Receptor. Journal of Medicinal Chemistry 2005, 48 (20) , 6423-6429.
    10. Victoria Magrioti,, Robert Verger, and, Violetta Constantinou-Kokotou. Triacylglycerols Based on 2-(N-tert-Butoxycarbonylamino)oleic Acid Are Potent Inhibitors of Pancreatic Lipase. Journal of Medicinal Chemistry 2004, 47 (2) , 288-291.
    11. Kevin R. Kozak,, Jeffery J. Prusakiewicz,, Scott W. Rowlinson,, Daniel R. Prudhomme, and, Lawrence J. Marnett. Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid Anandamide. Biochemistry 2003, 42 (30) , 9041-9049.
    12. Demetris P. Papahatjis,, Spyros P. Nikas,, Therapia Kourouli,, Ravi Chari,, Wei Xu,, Roger G. Pertwee, and, Alexandros Makriyannis. Pharmacophoric Requirements for the Cannabinoid Side Chain. Probing the Cannabinoid Receptor Subsite at C1‘. Journal of Medicinal Chemistry 2003, 46 (15) , 3221-3229.
    13. Judy Barnett-Norris,, Dow P. Hurst,, Diane L. Lynch,, Frank Guarnieri,, Alex Makriyannis, and, Patricia H. Reggio. Conformational Memories and the Endocannabinoid Binding Site at the Cannabinoid CB1 Receptor. Journal of Medicinal Chemistry 2002, 45 (17) , 3649-3659.
    14. Ma. Elena Y. Francisco,, Herbert H. Seltzman,, Anne F. Gilliam,, René A. Mitchell,, Sharyl L. Rider,, Roger G. Pertwee,, Lesley A. Stevenson, and, Brian F. Thomas. Synthesis and Structure−Activity Relationships of Amide and Hydrazide Analogues of the Cannabinoid CB1 Receptor Antagonist N-(Piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716). Journal of Medicinal Chemistry 2002, 45 (13) , 2708-2719.
    15. Edward W. Ng,, Mie Mie Aung,, Mary E. Abood,, Billy R. Martin, and, Raj K. Razdan. Unique Analogues of Anandamide:  Arachidonyl Ethers and Carbamates and Norarachidonyl Carbamates and Ureas. Journal of Medicinal Chemistry 1999, 42 (11) , 1975-1981.
    16. Wensheng Lang,, Ce Qin,, Sonyuan Lin,, Atmaram D. Khanolkar,, Andreas Goutopoulos,, Pusheng Fan,, Khaled Abouzid,, Zhaoxing Meng,, Diane Biegel, and, Alexandros Makriyannis. Substrate Specificity and Stereoselectivity of Rat Brain Microsomal Anandamide Amidohydrolase. Journal of Medicinal Chemistry 1999, 42 (5) , 896-902.
    17. Ruoxi Lan,, Qian Liu,, Pusheng Fan,, Sonyuan Lin,, Susanthi R. Fernando,, Deirdre McCallion,, Roger Pertwee, and, Alexandros Makriyannis. Structure−Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists. Journal of Medicinal Chemistry 1999, 42 (4) , 769-776.
    18. Sonyuan Lin,, Atmaram D. Khanolkar,, Pusheng Fan,, Andreas Goutopoulos,, Ce Qin,, Demetris Papahadjis, and, Alexandros Makriyannis. Novel Analogues of Arachidonylethanolamide (Anandamide):  Affinities for the CB1 and CB2 Cannabinoid Receptors and Metabolic Stability. Journal of Medicinal Chemistry 1998, 41 (27) , 5353-5361.
    19. David J. Drake,, Rader S. Jensen,, Jakob Busch-Petersen,, Joel K. Kawakami,, M. Concepcion Fernandez-Garcia,, Pusheng Fan,, Alexandros Makriyannis, and, Marcus A. Tius. Classical/Nonclassical Hybrid Cannabinoids:  Southern Aliphatic Chain-Functionalized C-6β Methyl, Ethyl, and Propyl Analogues. Journal of Medicinal Chemistry 1998, 41 (19) , 3596-3608.
    20. Demetris P. Papahatjis,, Therapia Kourouli,, Vasiliki Abadji,, Andreas Goutopoulos, and, Alexandros Makriyannis. Pharmacophoric Requirements for Cannabinoid Side Chains:  Multiple Bond and C1‘-Substituted Δ8-Tetrahydrocannabinols. Journal of Medicinal Chemistry 1998, 41 (7) , 1195-1200.
    21. William J. Ryan,, W. Kenneth Banner,, Jenny L. Wiley,, Billy R. Martin, and, Raj K. Razdan. Potent Anandamide Analogs:  The Effect of Changing the Length and Branching of the End Pentyl Chain. Journal of Medicinal Chemistry 1997, 40 (22) , 3617-3625.
    22. Herbert H. Seltzman,, Denise N. Fleming,, Brian F. Thomas,, Anne F. Gilliam,, Deirdre S. McCallion,, Roger G. Pertwee,, David R. Compton, and, Billy R. Martin. Synthesis and Pharmacological Comparison of Dimethylheptyl and Pentyl Analogs of Anandamide. Journal of Medicinal Chemistry 1997, 40 (22) , 3626-3634.
    23. Tzviel Sheskin,, Lumir Hanuš,, Joram Slager,, Zvi Vogel, and, Raphael Mechoulam. Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor. Journal of Medicinal Chemistry 1997, 40 (5) , 659-667.
    24. Brian F. Thomas,, Irma B. Adams,, S. Wayne Mascarella,, Billy R. Martin, and, Raj K. Razdan. Structure−Activity Analysis of Anandamide Analogs:  Relationship to a Cannabinoid Pharmacophore. Journal of Medicinal Chemistry 1996, 39 (2) , 471-479.
    25. Atmaram D. Khanolkar,, Vasiliki Abadji,, Sonyuan Lin,, W. Adam G. Hill,, Gihan Taha,, Khaled Abouzid,, Zhaoxing Meng,, Pusheng Fan, and, Alexandros Makriyannis. Head Group Analogs of Arachidonylethanolamide, the Endogenous Cannabinoid Ligand. Journal of Medicinal Chemistry 1996, 39 (22) , 4515-4519.
    26. Samah Shahen-Zoabi, Reem Smoum, Alexey Bingor, Etty Grad, Alina Nemirovski, Tawfeeq Shekh-Ahmad, Raphael Mechoulam, Rami Yaka. N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice. Translational Psychiatry 2023, 13 (1)
    27. Gina Granja-Galeano, Ana Paula Dominguez-Rubio, C. Daniel Zappia, Manuel Wolfson, Sara Sanz-Blasco, Julieta Aisemberg, Maria Zorrilla-Zubilete, Natalia Fernandez, Ana Franchi, Carlos P. Fitzsimons, Federico Monczor. CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation. Neuropharmacology 2023, 239 , 109674.
    28. Kimberly N. Karin, Mohammed A. Mustafa, Aron H. Lichtman, Justin L. Poklis. High‐performance liquid chromatography‐tandem mass spectrometry method for the analysis of N ‐oleoyl glycine and N ‐oleoyl alanine in brain and plasma. Journal of Separation Science 2023, 46 (22)
    29. Samah Shahen-Zoabi, Reem Smoum, Tehila Beiser, Alina Nemirovski, Raphael Mechoulam, Rami Yaka. N-Oleoyl Glycine and Its Derivatives Attenuate the Acquisition and Expression of Cocaine-Induced Behaviors. Cannabis and Cannabinoid Research 2023, 8 (5) , 812-823.
    30. Silvana Alfei, Gian Carlo Schito, Anna Maria Schito. Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review. Pharmaceutics 2023, 15 (7) , 1889.
    31. Stewart Ramsay, Nick J. Spencer, Vladimir Zagorodnyuk. Endocannabinoids, anandamide and 2-AG, regulate mechanosensitivity of mucosal afferents in the Guinea pig bladder. European Journal of Pharmacology 2023, 945 , 175624.
    32. Christopher S. Breivogel, Victor M. Pulgar. Synthetic cannabinoid receptor agonists compared to Δ9-tetrahydrocannabinol: Neurological effects and beyond. 2023, 487-496.
    33. Takaaki Sokabe, Heather B. Bradshaw, Makoto Tominaga, Emma Leishman, Avinash Chandel, Craig Montell. Endocannabinoids produced in photoreceptor cells in response to light activate Drosophila TRP channels. Science Signaling 2022, 15 (755)
    34. Sara Standoli, Sara Pecchioli, Daniel Tortolani, Camilla Di Meo, Federico Fanti, Manuel Sergi, Marina Bacci, Isabelle Seidita, Caterina Bernacchioni, Chiara Donati, Paola Bruni, Mauro Maccarrone, Cinzia Rapino, Francesca Cencetti. The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 Myoblasts. International Journal of Molecular Sciences 2022, 23 (19) , 11103.
    35. Lan-Yuan Zhang, Andrew Y. Kim, Joseph F. Cheer. Regulation of glutamate homeostasis in the nucleus accumbens by astrocytic CB1 receptors and its role in cocaine-motivated behaviors. Addiction Neuroscience 2022, 3 , 100022.
    36. Oindrila Rahaman, Dipyaman Ganguly. Endocannabinoids in immune regulation and immunopathologies. Immunology 2021, 164 (2) , 242-252.
    37. Samantha M. Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, Cheryl L. Limebeer, Erin M. Rock, Reem Smoum, Mathew Farag, Hannah de Almeida, Megan T. Sullivan, Sébastien Lacroix, Besma Boubertakh, Nayudu Nallabelli, Aron H Lichtman, Francesco Leri, Raphael Mechoulam, Vincenzo Di Marzo, Linda A. Parker. Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators. Frontiers in Pharmacology 2021, 12
    38. Myriam Dao, Helene François. Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox. Frontiers in Endocrinology 2021, 12
    39. Fengqiu Zhang, Burcu Özdemir, Phuong Quynh Nguyen, Oleh Andrukhov, Xiaohui Rausch-Fan. Methanandamide diminish the Porphyromonas gingivalis lipopolysaccharide induced response in human periodontal ligament cells. BMC Oral Health 2020, 20 (1)
    40. Alessia D’Aloia, Federica Arrigoni, Renata Tisi, Alessandro Palmioli, Michela Ceriani, Valentina Artusa, Cristina Airoldi, Giuseppe Zampella, Barbara Costa, Laura Cipolla. Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide. International Journal of Molecular Sciences 2020, 21 (23) , 9074.
    41. Samantha M. Ayoub, Reem Smoum, Mathew Farag, Harkirat Atwal, Stephen A. Collins, Erin M. Rock, Cheryl L. Limebeer, Fabiana Piscitelli, Fabio Arturo Iannotti, Aron H. Lichtman, Francesco Leri, Vincenzo Di Marzo, Raphael Mechoulam, Linda A. Parker. Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats. Psychopharmacology 2020, 237 (9) , 2753-2765.
    42. Lisa M. Wooldridge, Lipin Ji, Yingpeng Liu, Spyros P. Nikas, Alexandros Makriyannis, Jack Bergman, Brian D. Kangas. Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics 2020, 374 (3) , 462-468.
    43. Chris S. Breivogel, Jacob R. Wells, Amreen Jonas, Artik H. Mistry, Morgan L. Gravley, Rajul M. Patel, Brianna E. Whithorn, Bonnie M. Brenseke. Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ 9 -Tetrahydrocannabinol. Cannabis and Cannabinoid Research 2020, 5 (1) , 32-41.
    44. Li Shan Chiu, Ryan S. Anderton, Jane L. Cross, Vince W. Clark, Neville W. Knuckey, Bruno P. Meloni. Poly-arginine Peptide R18D Reduces Neuroinflammation and Functional Deficits Following Traumatic Brain Injury in the Long-Evans Rat. International Journal of Peptide Research and Therapeutics 2019, 25 (4) , 1563-1572.
    45. Saja Baraghithy, Reem Smoum, Malka Attar-Namdar, Raphael Mechoulam, Itai Bab, Joseph Tam. HU-671, a Novel Oleoyl Serine Derivative, Exhibits Enhanced Efficacy in Reversing Ovariectomy-Induced Osteoporosis and Bone Marrow Adiposity. Molecules 2019, 24 (20) , 3719.
    46. Sofia Papadogkonaki, Κostas Theodorakis, Kyriaki Thermos. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina. Experimental Eye Research 2019, 185 , 107694.
    47. Caitlin E. Scott, Yaliang Tang, Andrew Alt, Neil T. Burford, Samuel W. Gerritz, Lisa M. Ogawa, Litao Zhang, Debra A. Kendall. Identification and biochemical analyses of selective CB2 agonists. European Journal of Pharmacology 2019, 854 , 1-8.
    48. Julieta Lazarte, Robert A. Hegele. Cannabis effects on lipoproteins. Current Opinion in Lipidology 2019, 30 (2) , 140-146.
    49. Saja Baraghithy, Reem Smoum, Adi Drori, Rivka Hadar, Asaad Gammal, Shira Hirsch, Malka Attar-Namdar, Alina Nemirovski, Yankel Gabet, Yshaia Langer, Yehuda Pollak, Christian Patrick Schaaf, Megan Elizabeth Rech, Varda Gross-Tsur, Itai Bab, Raphael Mechoulam, Joseph Tam. Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and Activity. Journal of Bone and Mineral Research 2019, 34 (1) , 93-105.
    50. Wafa Hourani, Stephen P. H. Alexander. Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential. Brain and Neuroscience Advances 2018, 2 , 239821281878390.
    51. Yan Lu, Hope D. Anderson. Cannabinoid signaling in health and disease. Canadian Journal of Physiology and Pharmacology 2017, 95 (4) , 311-327.
    52. Massimiliano Beltramo. The cannabinoid system and its role in nociception. 2016, 169-200.
    53. Chaela S. Presley, Ammaar H. Abidi, Bob M. Moore. Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system. Analytical Biochemistry 2016, 498 , 8-28.
    54. Despina Kokona, Kyriaki Thermos. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways. Experimental Eye Research 2015, 136 , 45-58.
    55. Federica Messina, Ornelio Rosati, Massimo Curini, M. Carla Marcotullio. Cannabis and Bioactive Cannabinoids. 2015, 17-57.
    56. Yan Lu, Bolanle C. Akinwumi, Zongjun Shao, Hope D. Anderson. Ligand Activation of Cannabinoid Receptors Attenuates Hypertrophy of Neonatal Rat Cardiomyocytes. Journal of Cardiovascular Pharmacology 2014, 64 (5) , 420-430.
    57. Antonella Brizzi, Francesca Aiello, Pietro Marini, Maria Grazia Cascio, Federico Corelli, Vittorio Brizzi, Luciano De Petrocellis, Alessia Ligresti, Livio Luongo, Stefania Lamponi, Sabatino Maione, Roger G. Pertwee, Vincenzo Di Marzo. Structure–affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. Bioorganic & Medicinal Chemistry 2014, 22 (17) , 4770-4783.
    58. Bandana Chakravarti, Janani Ravi, Ramesh K. Ganju. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget 2014, 5 (15) , 5852-5872.
    59. Lina T Al Kury, Oleg I Voitychuk, Keun‐Hang Susan Yang, Faisal T Thayyullathil, Petro Doroshenko, Ali M Ramez, Yaroslav M Shuba, Sehamuddin Galadari, Frank Christopher Howarth, Murat Oz. Effects of the endogenous cannabinoid anandamide on voltage‐dependent sodium and calcium channels in rat ventricular myocytes. British Journal of Pharmacology 2014, 171 (14) , 3485-3498.
    60. Lina T. Al Kury, Keun-Hang Susan Yang, Faisal T. Thayyullathil, Mohanraj Rajesh, Ramez M. Ali, Yaroslav M. Shuba, Frank Christopher Howarth, Sehamuddin Galadari, Murat Oz. Effects of endogenous cannabinoid anandamide on cardiac Na+/Ca2+ exchanger. Cell Calcium 2014, 55 (5) , 231-237.
    61. Torbjörn U. C. Järbe, Brian J. LeMay, Aneetha Halikhedkar, JodiAnne Wood, Subramanian K. Vadivel, Alexander Zvonok, Alexandros Makriyannis. Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats. Psychopharmacology 2014, 231 (3) , 489-500.
    62. Lina T. Al Kury, Oleg I. Voitychuk, Ramiz M. Ali, Sehamuddin Galadari, Keun-Hang Susan Yang, Frank Christopher Howarth, Yaroslav M. Shuba, Murat Oz. Effects of endogenous cannabinoid anandamide on excitation–contraction coupling in rat ventricular myocytes. Cell Calcium 2014, 55 (2) , 104-118.
    63. H Li, J T Wood, K M Whitten, S K Vadivel, S Seng, A Makriyannis, H K Avraham. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. British Journal of Pharmacology 2013, 170 (3) , 489-505.
    64. Richard L. Anderson, Michael D. Randall, Susan L.F. Chan. The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans. European Journal of Pharmacology 2013, 706 (1-3) , 56-62.
    65. Leigh V. Panlilio, Zuzana Justinova, Steven R. Goldberg. Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacology & Therapeutics 2013, 138 (1) , 84-102.
    66. Padmanabha V. Kattamuri, Rebecca Salmonsen, Catherine McQuain, Sumner Burstein, Hao Sun, Guigen Li. Asymmetric synthesis of novel N-(1-phenyl-2,3-dihydroxypropyl)arachidonylamides and evaluation of their anti-inflammatory activity. Life Sciences 2013, 92 (8-9) , 506-511.
    67. Hyun-Ah Oh, Sojung Kwon, Soyoung Choi, Hyejin Shin, Kwang Ho Yoon, Wan Jong Kim, Hyunjung Jade Lim. Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos. MHR: Basic science of reproductive medicine 2013, 19 (2) , 93-101.
    68. Carol A. Paronis, Ganesh A. Thakur, Shama Bajaj, Spyros P. Nikas, V. Kiran Vemuri, Alexandros Makriyannis, Jack Bergman. Diuretic Effects of Cannabinoids. Journal of Pharmacology and Experimental Therapeutics 2013, 344 (1) , 8-14.
    69. Kyle M. Whitten, Alexandros Makriyannis, Subramanian K. Vadivel. Enzymatic synthesis of N-acylethanolamines: direct method for the aminolysis of esters. Tetrahedron Letters 2012, 53 (43) , 5753-5755.
    70. Cesar A. Ossola, Pablo N. Surkin, Antonela Pugnaloni, Claudia E. Mohn, Juan C. Elverdin, Javier Fernandez-Solari. Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats. Inflammation Research 2012, 61 (9) , 941-948.
    71. Joseph K. Ritter, Cao Li, Min Xia, Justin L. Poklis, Aron H. Lichtman, Rehab A. Abdullah, William L. Dewey, Pin-Lan Li. Production and Actions of the Anandamide Metabolite Prostamide E2 in the Renal Medulla. Journal of Pharmacology and Experimental Therapeutics 2012, 342 (3) , 770-779.
    72. Spyros P. Nikas, Marsha D'Souza, Alexandros Makriyannis. Enantioselective synthesis of (10S)- and (10R)-methyl-anandamides. Tetrahedron 2012, 68 (31) , 6329-6337.
    73. Douglas McHugh, Jeremy Page, Emily Dunn, Heather B Bradshaw. Δ 9 ‐Tetrahydrocannabinol and N ‐arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC‐1B cells. British Journal of Pharmacology 2012, 165 (8) , 2414-2424.
    74. George Kokotos. Endocannabinoids. 2012, 245-264.
    75. Paul J Brighton, Timothy H Marczylo, Shashi Rana, Justin C Konje, Jonathon M Willets. Characterization of the endocannabinoid system, CB1 receptor signalling and desensitization in human myometrium. British Journal of Pharmacology 2011, 164 (5) , 1479-1494.
    76. Zuzana Justinová, Sevil Yasar, Godfrey H. Redhi, Steven R. Goldberg. The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously Self-Administered by Squirrel Monkeys. The Journal of Neuroscience 2011, 31 (19) , 7043-7048.
    77. D. Matthew Walentiny, Thomas F. Gamage, Jonathan A. Warner, Thanh K. Nguyen, Darren B. Grainger, Jenny L. Wiley, Robert E. Vann. The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆9-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice. European Journal of Pharmacology 2011, 656 (1-3) , 63-67.
    78. Olga Asimaki, Dimitra Mangoura. Cannabinoid receptor 1 induces a biphasic ERK activation via multiprotein signaling complex formation of proximal kinases PKCɛ, Src, and Fyn in primary neurons. Neurochemistry International 2011, 58 (2) , 135-144.
    79. Alejandra Delgado, Erica H. Jaffé. Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids—Cannabinoids and Acute Stress Modulate GABA Release. International Journal of Cell Biology 2011, 2011 , 1-10.
    80. R. G. Pertwee, A. C. Howlett, M. E. Abood, S. P. H. Alexander, V. Di Marzo, M. R. Elphick, P. J. Greasley, H. S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, R. A. Ross. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB 1 and CB 2. Pharmacological Reviews 2010, 62 (4) , 588-631.
    81. Ilona Kubajewska, Cris S. Constantinescu. Cannabinoids and experimental models of multiple sclerosis. Immunobiology 2010, 215 (8) , 647-657.
    82. Matthew W. Buczynski, Camilla I. Svensson, Darren S. Dumlao, Bethany L. Fitzsimmons, Jae‐Hang Shim, Thomas J. Scherbart, Faith E. Jacobsen, Xiao‐Ying Hua, Tony L. Yaksh, Edward A. Dennis. Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord. Journal of Neurochemistry 2010, 114 (4) , 981-993.
    83. Demetris P. Papahatjis, Victoria R. Nahmias, Spyros P. Nikas, Marion Schimpgen, Alexandros Makriyannis. Design and Synthesis of (13 S )‐Methyl‐Substituted Arachidonic Acid Analogues: Templates for Novel Endocannabinoids. Chemistry – A European Journal 2010, 16 (13) , 4091-4099.
    84. Andrea Giuffrida, Lance R. McMahon. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: Therapeutic implications in Parkinson's disease and abuse liability. Prostaglandins & Other Lipid Mediators 2010, 91 (3-4) , 90-103.
    85. Murat Oz, Vanaja Jaligam, Sehamuddin Galadari, George Petroianu, Yaroslav M. Shuba, Toni S. Shippenberg. The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor‐independent mechanism. Journal of Neurochemistry 2010, 112 (6) , 1454-1464.
    86. Tamaki Hayase, Yoshiko Yamamoto, Keiichi Yamamoto. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. Journal of Pharmacy and Pharmacology 2010, 53 (11) , 1525-1532.
    87. Juha Juntunen, Tomi Järvinen, Riku Niemi. In-vitro corneal permeation of cannabinoids and their water-soluble phosphate ester prodrugs. Journal of Pharmacy and Pharmacology 2010, 57 (9) , 1153-1157.
    88. Torbjörn U. C. Järbe, Chen Li, Subramanian K. Vadivel, Alexandros Makriyannis. Discriminative stimulus functions of methanandamide and ∆9-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol. Psychopharmacology 2010, 208 (1) , 87-98.
    89. Ganesh A Thakur, Ritesh Tichkule, Shama Bajaj, Alexandros Makriyannis. Latest advances in cannabinoid receptor agonists. Expert Opinion on Therapeutic Patents 2009, 19 (12) , 1647-1673.
    90. Saniya Aggarwal, Behnam Shavalian, Esther Kim, Scott M. Rawls. Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception. Pharmacology Biochemistry and Behavior 2009, 93 (4) , 426-432.
    91. SM Gardiner, JE March, PA Kemp, T Bennett. Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats. British Journal of Pharmacology 2009, 158 (4) , 1143-1152.
    92. Faith R. Kreitzer, Nephi Stella. The therapeutic potential of novel cannabinoid receptors. Pharmacology & Therapeutics 2009, 122 (2) , 83-96.
    93. Torbjörn U. C. Järbe, Chen Li, Qian Liu, Alexandros Makriyannis. Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog. Psychopharmacology 2009, 203 (2) , 229-239.
    94. Lance R. McMahon. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Δ9-tetrahydrocannabinol. Psychopharmacology 2009, 203 (2) , 219-228.
    95. Lumír Ondřej Hanuš. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Medicinal Research Reviews 2009, 29 (2) , 213-271.
    96. Bruce A. Rasmussen, Esther Kim, Ellen M. Unterwald, Scott M. Rawls. Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism. Brain Research 2009, 1260 , 7-14.
    97. V. Kiran Vemuri, Alexandros Makriyannis. Endocannabinoids and Their Synthetic Analogs. 2009, 21-48.
    98. Catherine E. Goodfellow, Michelle Glass. Chapter 4 Anandamide Receptor Signal Transduction. 2009, 79-110.
    99. David R. Janero, Subramanian K. Vadivel, Alexandros Makriyannis. Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategies. International Review of Psychiatry 2009, 21 (2) , 122-133.
    100. Fenmei Yao, Chen Li, Subramanian K. Vadivel, Anna L. Bowman, Alexandros Makriyannis. Development of novel tail-modified anandamide analogs. Bioorganic & Medicinal Chemistry Letters 2008, 18 (22) , 5912-5915.
    Load more citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect